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Oxidation of 2,3-cis-2-sulfonamide-N-butenoate-azetidinone 3 and
2,3-trans-2-acetoxy-N-butenoate-azetidinone 6 led to the formation
of azetidinone-oxiranes 5 and 7. Molecular structure of 5, including
its absolute configuration, was unambiguously determined by X-ray
structure analysis. Cleavage of the benzyl ester group using AlCl3 /
anisole as well as H2Pd /C procedures failed. Instead, new methods
for the removal of the substituent from the azetidinone nitrogen of
compounds 5 and 7 were found. Azetidinone 8 was isolated in the
reaction of azetidinone-oxiranes 5 with AlCl3 / anisole. During hy-
drogenation of azetidinone-oxirane 5, afforded azetidinone -hydro-
xy acid sodium salt 9, which was transformed into azetidinone 8 in
acidic media. Compounds 5 and 7 gave the azetidinone-halohydri-
nes 10 and 11 by the oxirane ring opening with HCl.
Key words: azetidinone-N-butenoat, azetidinone-oxirane, azetidino-
ne -hydroxy acid, azetidinone-halohydrine, synthesis, X-ray struc-
ture analysis, antibacterial activity.
INTRODUCTION
The unresolved problem of the -lactamase mediated resistance of clini-
cally important bacteria to -lactam antibiotics has encouraged the search
for more effective inhibitors of these enzymes.
* Author to whom correspondence should be addressed. (E-mail: kojic@rudjer.irb.hr)
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In last two decades there has been a considerable expansion of efforts
devoted to the search for new -lactamase inhibitors by chemical transfor-
mation of natural penicillins. Some of the semi-synthetic inhibitors, like sul-
bactam, brobactam, tazobactam, cloxacillin sulfoxide and others have been
shown to be potent -lactamase inhibitors.1
Here we present the synthesis, structure elucidation and reactivity of
some novel -lactam species derived from cloxacillin.
RESULTS AND DISCUSSION
Cloxacillin 1 was transformed into 2-sulfonamide-azetidinone 3 using our
earlier established methodology.2 In spite of the fact that unsaturated acids
react with peracids with great difficulty to form oxirane derivatives,3 the re-
action of 3 with m-chloroperbenzoic acid (m-CPBA) resulted in generation of
2-sulfonamide-azetidinone-oxirane 5 in good yield, Scheme 1.
X-ray structure analysis was used to determine the molecular structure
of azetidinone-oxirane 5 and to define its absolute configuration. The known
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Figure 1. Molecular structure (ORTEP II) of (2R,3R)-1-(1R)-1'-Benzyloxycarbonyl-
2’-methyl-1’,2’-epoxyprop-1’-yl-2-isopropylaminosulphonyl-3-3’-(o-chlorophenyl)-5’-
methyl-isoxazol-4’-yl-carbonylamino-4-oxoazetidine 5.
chirality R of two carbon atoms of the -lactam ring were used as the inter-
nal standard to determine the configuration of a new chiral centre of the
oxirane ring (Figure 1); its configuration proved to be R. The anomalous dis-
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persion values of sulphur and chlorine are used as an alternative approach
to determine the absolute configuration of three chiral carbon atoms. The
-lactam ring is planar the mean torsion angle is 0.8(6)°. Van der Waals
contacts define the crystal packing. Intramolecular hydrogen bond N3–H3O6
N3O6, 2.969(8)Å; N3–H, 0.86(1)Å; and angle N3–HO6, 118(2)° stabilize
the overall conformation of the folded shape.
Furthermore, 2-acetyloxy-azetidinone-oxirane 7 was also generated by ox-
idation of 6 with m-CPBA, Scheme 2.
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Scheme 2.
Formation of azetidinone-oxazoline 4 was carried out by treating 2-sul-
finamide-azetidinone 2 with N-chlorosuccinimide. The reaction of 4 with
acetic acid in the presence of hydrogen chloride4 affords 2,3-trans-2-acetyl-
oxy-azetidinone-butenoat 6.
The stereochemical assignment of 6 is readily made by virtue of its H2-H3
coupling constant J = 1.2 Hz, diagnostic of their trans relative orientation.5
New methods for the removal of the substituent from the azetidinone ni-
trogen of compounds 5 and 7 were found. Attempts to prepare the corre-
sponding carboxylic acid derivatives by the benzyl group cleavage failed. In-
stead, in the reaction of azetidinone-oxirane 5 with AlCl3/anisole,
6 azetidi-
none 8 was produced in 80% yield. Furthermore, during hydrogenolysis of
azetidinone-oxirane 5 with palladium on charcoal in ethanolic solution in the
presence of sodium bicarbonate the azetidinone -hydroxy acid sodium salt
9 was prepared in 87% yield. Treated with acids, compound 9 was trans-
formed into azetidinone 8, Scheme 1.
Finally, the removal of the substituent on the azetidinon nitrogen was
carried out with a catalytic amount of p-TSA; azetidinone-oxirane 5 (7) af-
fords azetidinone 8 (12), Schemes 1 and 2.
The reactivity of azetidinone-oxiranes 5 and 7 was also studied in reac-
tions with hydrochloric acid. Compounds 5 and 7 gave the azetidinone-halo-
hydrines 10 and 11 by the oxirane ring opening with HCl. The fact that,
upon the action of hydrochloric acid, both 5 and 7 gave a product with the
same halohydrine side-chain substantiates the identical steric structure of
the oxirane rings in these compounds.
The mechanism of the oxirane ring opening in hydrochloric acid media
involves primarly addition of a proton to the oxygen and forming of an oxi-
ranium ion 13. In the next step, the nucleophile (Cl–) is attached to the car-
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Scheme 3.
bon atom in position 2’ (ß-carbon atom), which is probably a sterically prefe-
rable site for generating azetidinone halohydrines 10 or 11, Scheme 3.
In conclusion, in spite of the fact that unsaturated acids react with per-
acids with great difficulty to form oxirane derivatives, oxidation of 2,3-cis-2-
sulfonamide-N-butenoate-azetidinone 3 and 2,3-trans-2-acetoxy-N-buteno-
ate-azetidinone 6 with m-CPBA led to the formation of azetidinone-oxiranes
5 and 7.
Molecular structure of 5, including its absolute configuration, was un-
ambiguously determined by X-ray structure analysis.
New methods for the removal of the substituent from the azetidinone ni-
trogen of compounds 5 and 7 were found using AlCl3 / anisole or p-TsOH.
Opening of the oxirane ring by using H2/Pd/NaHCO3 gave azetidinone -hy-
droxy acid whose reaction in acidic media offers a new possibility of remov-
ing the substituent from the azetidinone nitrogen atom.
Finally, azetidinone-oxiranes gave azetidinone-halohydrines by the oxi-
rane ring opening with HCl.
Novel azetidinone derivatives (monobactames) did not show any signifi-
cant intrinsic antibacterial activity against S.aureus B008 and E.coli ATCC
35218, nor synergistic activity with amoxycillin.
EXPERIMENTAL
Melting points were determined using a Fischer-Johns apparatus and were un-
corrected. IR spectra were recorded using a Perkin-Elmer Model 257G or Nicolet
Magna 760 IR Spectrometer. 1H and 13C NMR were recorded on a Varian Gemini
XL-300 spectrometer using TMS as the internal standard. Chemical shifts, , were
in ppm downfield to Me4Si and J values were given in Hz. Mass spectra were deter-
mined using the fast bombardment method with an Auto Spec Q (VG Analytical)
mass spectrometer. Tlc was run on Merck Kieselgel HF254 plates and spots were vi-
sualized under UV light or I2 vapour adsorption following water flush. Column chro-




Cloxacillin sodium (10 g, 22 mmol) was dissolved in N,N-dimethylformamide
(600 mL) and benzyl bromide (2.9 mL, 24 mmol) was added. After being stirred for 5
hours at room temperature, the reaction mixture was added dropwise into ice-water
(600 mL). The resulting mixture was allowed to warm to room temperature, stirred
for a further 2 hours and decanted. The crude product was dissolved in dichloro-
methane (200 mL), the solution was dried (Na2SO4) and evaporated under reduced
pressure. Purification of the residue by silica gel chromatography in benzene–ethyl-
acetate (5:1) gave the benzyl penicillinate as a white solid (7.18 g, 67.6%): m.p. 60–
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62 °C; Rf = 0.54 in benzene–ethylacetate (5:1); IR (film) max/cm–1: 3400m, 1785vs,
1740s, 1670vs, 1600m, 1500m, 1440–1150bm, 1295s, 1200m, 1185m, 750m, 700m; 1H
NMR (CDCl3) /ppm: 1.32 (6H, s, CMe2), 2.78 (3H, s, Me), 4.33 (1H, s, C3H), 5.15
(2H, s, CH2), 5.44 (1H, d, J = 4.3 Hz, C5H), 5.76 (1H, dd, J = 4.3 and 9.3 Hz, C6H),
5.97 (1H, d, J = 9.3Hz, CONH), 7.57–7.26 (9H, m, C6H4 and C6H5).
Anal. Calcd. for C26H24N3ClO5S (Mr = 525.99): C 59.37, H 4.60, N 7.98, Cl 6.74, S
6.10%; found C 59.33, H 4.69, N 7.92, Cl 6.73, S 6.06%.
(3S,5R,6R) Benzyl 6-3’-(o-chlorophenyl)-5’-methyl-4’-isoxazolylcarbonyl-
amino penicillinate sulphoxide
The benzyl ester of cloxacilline (7.2 g, 14 mmol) was dissolved in 80% acetic acid
(30 mL) and 30% hydrogen peroxide (2.5 mL) was added. Reaction mixture was stir-
red at room temperature for 10 hours and then added dropwise into ice-water (60
mL). The resulting suspension was stirred at room temperature for 5 hours and fil-
tered. The solid was washed with water and dried in air (4.8 g, 66.5%). Crystalliza-
tion from ethylacetate afforded benzyl penicillinate sulfoxide as a white crystalline
solid: m.p. 153–155 C; Rf = 0.36 in benzene–ethylacetate (5:1); IR (CH2Cl2) max/cm–1:
3360s, 1790vs, 1755vs, 1675vs, 1605s, 1500vs, 1455m, 1340m, 1295m, 1270m,
1205vs, 1035m, 765m, 755s, 735s, 700m; 1H NMR (CDCl3) /ppm: 1.02 and 1.55 (6H,
2s, CMe2), 2.73(3H, s, Me), 4.53 (1H, s, C3H), 4.96 (1H, d, J = 4.6Hz, C5H), 5.14 and
5.26 (2H, 2d, J = 11.7Hz, CH2), 6.12 (1H, dd, J = 4.6 and 10.3 Hz, C6H), 6.90 (1H, d,
J = 10.3 Hz, CONH), 7.27–7.53 (9H, m, C6H5 and C6H4).
Anal. Calcd. for C26H24N3ClO6S (Mr = 542.00): C 57.61, H 4.46, N 7.75, Cl 6.54; S




A suspension of toluene (200 mL) and calcium oxide (1.22 g, 22 mmol) was heat-
ed in an equipment having a Dean-Stark water trap to remove azeotropically any
moisture. To the resulting dried toluene (180 mL), benzyl penicillinate sulfoxide (2.0 g,
3.7 mmol) and N-chlorosuccinimide (0.55 g, 4.15 mmol) were added. The mixture was
refluxed for 1.5 h, cooled to 15 C and isopropylamine (0.9 mL, 11 mmol) was added.
The reaction mixture was stirred at room temperature for 3 hours and then filtered.
The filtrate was washed with water (3  30 mL), dried (Na2SO4) and evaporated un-
der reduced pressure (foam, 2.06 g, 93%). Crude product (1 g) was purified by silica
gel with dichloromethane–ethylacetate (4:1); two epimeric sulfinamides were obtai-
ned.
Compound 2a. – 221 mg (21%): m.p. 53 C; Rf = 0.32 in dichloromethane–ethyl-
acetate (4:1): IR (KBr) max/cm–1: 3310–3290bm, 1780vs, 1725m, 1675s, 1605m, 1515–
1495bm, 1450–1430bm, 1385m, 1365m, 1290m, 1210s, 1110m, 1060m, 970m, 695m;
1H NMR (CDCl3) /ppm: 1.04 and 1.06 (6H, 2d, J = 6.3 Hz, CHMe2), 2.09 and 2.22
(6H, 2s, CMe2), 2.75 (3H, s, Me), 3.31–3.38 (2H, m, S–NH and CHMe2), 4.81 (1H, d, J
= 5.4 Hz, C2H), 5.12 and 5.30 (2H, 2d, J = 12.3 Hz, CH2), 5.71 (1H, dd, J = 5.1 and
9.9 Hz, C3H), 6.37 (1H, d, J = 9.9 Hz, CONH), 7.23–54 (9H, m, C6H5 and C6H4).
NOVEL AZETIDINONE-OXIRANES 217
Compound 2b. – 535 mg (50%): m.p. 65 C; Rf = 0.22 in dichloromethane–ethyl-
acetate (4:1); IR (KBr) max/cm–1: 3410–3220bw, 1780vs, 1720m, 1672s, 1600m, 1580–
1495bm, 1385m, 1365m, 1290m, 1215s, 1055s, 970w, 755m, 705w; 1H NMR (CDCl3)
/ppm : 1.08 and 1.10 (6H, 2d, J = 6.0 Hz, CHMe2), 1.96 and 2.24 (6H, 2s, CMe2),
2.80 (3H, s, Me), 3.38 (1H, m, CHMe2), 3.86 (1H, d, J = 6.3 Hz, S-NH), 4.66 (1H, d, J
= 5.1 Hz, C2H), 5.14 and 5.25 (2H, 2d, J = 12.2 Hz, CH2), 5.73 (1H, dd, J = 4.8 and




Formic acid (13.0 mL) and a 30% aqueous solution of hydrogen peroxide (35 mL)
were added to the solution of 2 (4.0 g, 6.5 mmol) in dichloromethane (160 mL). The
mixture was stirred for 5 hours at room temperature, whereafter water (80 mL) and
dichloromethane (160 mL) were added. The organic layer was separated, washed
with water (80 mL), dried (Na2SO4) and evaporated. Purification of the residue by
silica gel chromatography in dichloromethane–ethylacetate (4:1) gave 3 (3.6 g, 89%)
as a white foam: m.p. 75 C; Rf = 0.80 in dichloromethane–ethylacetate (4:1); IR
(CH2Cl2) max/cm–1: 3400m, 1790vs, 1730s, 1685vs, 1605s, 1520vs, 1440–1425bm,
1390m, 1370m, 1335s, 1290m, 1260m, 1215s, 1060m, 1005m, 895m, 760s, 700m; 1H
NMR (CDCl3) /ppm: 0.98 and 1.03 (6H, 2d, J = 6.6 Hz, CHMe2), 1.92 and 2.23 (6H,
2s, CMe2), 2.78 (3H, s, Me), 3.29 (1H, m, CHMe2), 3.83 (1H, d, J = 8.1 Hz, S-NH),
4.96 (1H, d, J = 5.1 Hz, C2H), 5.07 and 5.30 (2H, 2d, J = 12.1 Hz, CH2), 5.86 (1H, dd,
J = 5.1 and 10.2 Hz, C3H), 6.30 (1H, d, J = 10.2 Hz, CONH), 7.27–7.55 (9H, m, C6H5
and C6H4); 13C NMR (CDCl3) /ppm: 12.9, 21.9, 23.6, 23.8, 23.9,46.4, 56.6, 66.8, 72.2,
111.0, 118.6, 126.8, 127.4, 128.5, 128.6, 128.7, 130.4, 131.4, 131.7, 133.9, 135.0,
156.0, 158.4, 160.6, 162.4, 164.6, 174.7.
Anal. Calcd. for C29H31N4O7SCl (Mr = 615.09): C 56.62, H 5.08, N 9.11, S 5.21, Cl




-3-3’-(o-chlorophenyl)-5’-methylisoxazol-4’-yl-carbonylamino-4-oxo-azetidine 2 (308 mg,
0.5 mmol) was dissolved in dichloromethane (6 mL) and N-chlorosuccinimide (134 mg, 1
mmol) was added. The reaction mixture was stirred at room temperature for 2
hours, then washed with water (6 mL). The organic phase was dried (Na2SO4), fil-
tered and evaporated under reduced pressure. The residue was purified by silica gel
column chromatography and eluted with dichloromethane–ethylacetate (15:1) to give
cis-oxazoline-azetidinone 4 as a yellowish foam (150 mg, 62%): Rf = 0.46 in dichloro-
methane–ethylacetate (15:1); IR (CH2Cl2) max/cm–1: 1780vs, 1725s, 1665s, 1645m,
1610m, 1500w, 1455mb, 1385m, 1365m, 1285m, 1265–1245mb, 1215vs, 1185m, 1155w,
1105–1075mb, 1030m, 970s, 895m, 880m, 835m, 750sb, 700s, 645w; 1H NMR
(CDCl3) /ppm : 1.79 and 2.22 (6H, 2s, CMe2), 2.71 (3H, s, Me), 5.22–5.07 (3H, m,
CH2C6H5 and C2H), 5.86 (1H, d, J = 3.2 Hz, C3H), 7.26–7.45 (9H, m, C6H5 and C6H4);
13C NMR (CDCl3) /ppm: 13.0, 21.6, 23.2, 29.4, 66.8, 80.9, 87.0, 106.0, 118.8, 126–
131.0, 133.9, 135.2, 155.3, 160.3, 163.0, 165.7, 173.4.
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Anal. Calcd. for C26H22N3O5Cl (Mr = 491.92): C 63.48, H 4.51, N 8.54, Cl 7.21%;




Procedure (a). – To a solution of sulfonamide 3 (2.0 g, 3.3 mmol) in dichlorome-
thane (100 mL), m-chloroperbenzoic acid (0.62 g, 3.57 mmol) in dichloromethane (30
mL) was added. The resulting mixture was stirred for 40 hours at room tempera-
ture. Then, it was washed with saturated aqueous sodium hydrogen carbonate (50
mL) and the layers were separated. Evaporation of dry (Na2SO4) organic layer under
reduced pressure gave a white foam. After purification with silica gel chromatogra-
phy eluted with dichloromethane–ethylacetate (10:1), it gave epoxide 5 (790 mg,
38.5%). A small sample was recrystallized from isopropanol giving an analytical
sample as a white crystalline solid; m.p. 142–143 C; Rf = 0.47 in dichloromethane–
ethylacetate (10:1); IR (CH2Cl2) max/cm-1: 3400m, 3320s, 1800vs, 1755s, 1735m,
1680vs, 1535–1505bs, 1460m, 1375m, 1335s, 1270–1240mb, 1125s, 1060m, 1005m,
760s, 735s, 700m; 1H NMR (CDCl3) /ppm: 0.98 and 1.17 (6H, 2d, J = 6.6 Hz,
CHMe2), 1.43 and 1.52 (6H, 2s, CMe2), 2.76 (3H, s, Me), 3.47–3.54 (1H, m, CHMe2),
4.54 (1H, d, J = 5.4 Hz, C2H), 4.80 (1H, d, J = 7.7 Hz, S-NH), 5.17 and 5.32 (2H, 2d, J
= 11.8 Hz, CH2), 5.91 (1H, dd, J = 5.4 and 10.5 Hz, C3H), 6.29 (1H, d, J = 10.2 Hz,
CONH), 7.27–7.51 (9H, m, C6H5 and C6H4); 13C NMR (CDCl3) /ppm: 13.0, 18.8, 21.4,
22.9, 24.3, 46.7, 57.9, 68.2,68.7, 69.4, 70.7, 111.0, 126.6, 127.1, 128.6, 128.8, 128.9,
129.0, 129.1, 130.1, 131.4, 133.9, 134.1, 158.6, 160.4, 163.9, 164.3, 174.2; MS m/z:
631 (M 100%).
Anal. Calcd. for C29H31N4ClO8S (Mr = 631.11): C 55.19, H 4.95, N 8.88, Cl 5.62, S
5.08%; found C 55.00, H 5.22, N 8.58, Cl 5.95, S 4.86%.
Procedure (b). – The solution of sulfonamide 3 (200 mg, 0.32 mmol) in dichloro-
methane (10 mL) was cooled to +5 C, 30% aq. solution of hydrogen peroxide (20 mL)
and formic acid (0.6 mL) were added. The mixture was stirred for 35 hours at +5 C
and the layers were separated. The organic phase was washed with water, dried
(Na2SO4) and evaporated in vacuo. Chromatography on silica gel, using dichlorome-
thane–ethylacetate (10:1) as eluents gave 5 (65 mg, 32.7%); spectral data as in pro-
cedure (a).
Procedure (c). – Sulfinamide 2 (200 mg, 0.33 mmol) was dissolved in dichloro-
methane (20 mL) and m-chloroperbenzoic acid (120 mg, 0.70 mmol) in dichlorome-
thane (6 mL) was added. The solution was stirred for 50 hours at room temperature
and then worked up according to procedure (a). After the purification of a crude pro-
duct on a silica gel column by means of the solvent mixture dichloromethane–ethyl-




To a solution of oxazoline-azetidinone 4 (2 g, 4 mmol) in dichloromethane (20 mL),
80% acetic acid (20 mL) was added. Hydrogen chloride (gaseous) was introduced into
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the reaction mixture at room temperature to saturation. The resulting mixture was
stirred at room temperature for 20 hours and evaporated in vacuo. The residue was
worked up two times with dichloromethane (20 mL), then chromatographed on a sil-
ica gel column eluted with dichloromethan–ethylacetate (4:1) to yield 6 (450 mg,
20.4%): Rf = 0.55 in dichloromethane–ethylacetate (4:1); IR (KBr) max/cm–1: 3417mb,
1786vs, 1763s, 1718m, 1676s, 1605w, 1522m, 1456w, 1396m, 1371m, 1221vs, 1178m,
1034m, 766w, 698w; 1H NMR (CDCl3) /ppm: 1.92 and 2.03 (6H, 2s, CMe2), 2.20 (3H,
s, OCOCH3), 2.73 (3H, s, Me), 4.89 (1H, dd, J = 1.2 and 7.2 Hz, C3H), 5.18 (2H, d, J =
1.2 Hz, CH2), 5.66 (1H, d, J = 7.1 Hz, CONH), 5.98 (1H, d, J = 1.2 Hz, C2H), 7.32–
7.52 (9H, m, C6H5 and C6H4); 13C NMR (CDCl3) /ppm: 12.8, 18.7, 20.3, 21.6, 23.1,
29.4, 61.8, 66.8, 82.6, 110.9, 119.2, 126.9–132.1, 133.8, 135.6, 154.3, 158.3, 161.1,
162.8, 170.1, 174.8.
Anal. Calcd. for C28H26N3ClO7 (Mr = 551.97): C 60.92, H 4.75, N 7.61, Cl 6.42%;
found C 60.94, H 4.99, N 7.59, Cl 6.42 %.
(2S,3R)-1-(1’-Benzyloxycarbonyl-2’-methyl-1’,2’-epoxypropyl)-2-acetyloxy-3-
3’-(o-chlorophenyl)-5’-methylisoxazol-4’-ylcarbonylamino-4-oxoazetidine (7)
Compound 6 (160 mg, 0.28 mmol) was dissolved in dichloromethane (5 mL) and
m-chloroperbenzoic acid (60 mg, 0.34 mmol) was added. The reaction mixture was
stirred at room temperature for 44 hours, then washed with saturated aqueous so-
dium hydrogen carbonate. The organic layer was dried (Na2SO4), filtered and evapo-
rated under reduced pressure. The crude product was purified on silica gel chroma-
tography using dichloromethane–ethylacetate (4:1) as eluent and compound 7 was
obtained as a white foam (60 mg, 36%): Rf = 0.64 in dichloromethane–ethylacetate
(4:1); IR (KBr) max/cm–1 3410s, 1801vs, 1753vs, 1676s, 1605w, 1522m, 1387m, 1282w,
1232s, 1184s, 1134m, 1036m, 766m, 752m; 1H NMR (CDCl3) /ppm:1.36 and 1.50
(6H, 2s, CMe2), 2.11 (3H, s, OCOCH3), 2.73 (3H, s, Me), 4.92 (1H, d, J = 7.2 Hz, C3H),
5.28 (2H, ABq, J = 12.3 and 24 Hz, CH2), 5.69 (1H, d, J = 7.2 Hz, CONH), 5.79 (1H,
s, C2H), 7.39–7.55 (9H, m, C6H5 and C6H4).
Anal. Calcd. for C28H26N3ClO8 (Mr = 567.97): C 59.21, H 4.61, N 7.30, Cl 6.24%;
found C 59.02, H 4.81, N 7.39, Cl 6.38 %.
(2R,3R)-2-Isopropylaminosulphonyl-3-3’-(o-chlorophenyl)-5’-methylisoxazol-
4’-yl-carbonylamino-4-oxoazetidine (8)
Procedure (a). – The suspension of AlCl3 (1.2 g, 8.3 mmol) in dichloromethane
(30 mL) was cooled at 10 C and a stream of nitrogen was introduced. Then, the so-
lutions of epoxide 5 (870 mg, 1.37 mmol) in dichloromethane (10 mL) and anisole (2
mL, 16.4 mmol) were added. The resulting mixture was stirred at –10 C for 30 min.
and at 0 C for a further 4 hours. To the reaction mixture, water (10 mL) was added
and acidified with HCl 1:1 to pH = 1.0. The layers were separated, the organic layer
was washed with water (10 mL), dried (Na2SO4), filtered and evaporated in vacuo.
The crude product was purified on silica gel, eluted with dichloromethane–methanol
(4:1) yielding 8 (470 mg, 80.3%). A small sample was recrystallized from dichloro-
methane giving an analytical sample as a white crystalline solid: m.p. 178–179 C;
Rf = 0.62 in dichloromethane–methanol (9:1); IR (KBr) max/cm–1: 3399s, 3301s,
1797vs, 1787vs, 1650vs, 1597m, 1516m, 1423w, 1327w, 1288w, 1205w, 1159w, 1130w,
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1058vw, 1010w, 918vw, 769w; 1H NMR (DMSO-d6) /ppm: 1.09 and 1.121 (6H, 2d, J
= 6.2 Hz, CHMe2), 2.68 (3H, s, Me), 3.25–3.53 (1H, m, CHMe2), 4.94 (1H, d J = 4.8
Hz, C2H), 5.68 (1H, dd, J = 4.8 and 9.3 Hz, C3H), 7.39–7.59 (4H, m, C6H4), 8.18 (1H,
d, J = 9.3 Hz, CONH); 13C NMR (DMSO) /ppm: 12.6, 24.0, 24.4, 45.6, 58.1, 67.8,
112.8, 127.6, 127.7, 130.0, 131.7, 131.8, 132.9, 160.1, 160.8., 167.7, 171.5.
Anal. Calcd. for C17H19N4SO5Cl (Mr = 426.87): C 47.82, H 4.49, N 13.12, S 7.51,
Cl 8.39%; found C 47.80, H 4.77, N 12.98, S 7.67, Cl 8.97%.
Procedure (b). – Oxirane 5 (200 mg, 0.32 mmol) was dissolved in absolute etha-
nol (12 mL) and p-toluensulphonic acid was added (30 mg). The rection mixture was
heated under reflux for 4.5 hours, cooled and evaporated under reduced pressure.
The residue was worked-up with dichloromethane (2  10 mL) and purified by silica
gel column chromatography eluted with dichloromethane–methanol (9:1) to give aze-
tidinone 8 (28 mg; 21%) of spectroscopic properties identical to those described above.
Procedure (c). – Compound 9 (100 mg, 0.18 mmol) was dissolved in water (4 mL)
and HCl 1M was added to pH = 2.0. The resulting suspension was stirred at room
temperature for 1 hour, then filtered and dried in air yielding 8 (50 mg; 65.1%). The
product was identical to the one described in (a).
(2R,3R)-1-(1’-Carboxyl-2’-methyl-2’-hydroxypropyl)-2-isopropylaminosulpho-
nyl-3-3’-(o-chlorophenyl)-5’-methylisoxazol-4’-yl-4-oxoazetidine sodium salt (9)
Oxirane 5 (260 mg, 0.41 mmol) was dissolved in absolute ethanol (30 mL), satu-
rated aqueous solution NaHCO3 (0.7 mL) and 10% Pd/C (26 mg) were added and
treated with hydrogen under pressure (2 Atm.) for 1 hour. The mixture was filtered
and the filtrate was evaporated under reduced pressure to a white foam. After puri-
fication by silica gel chromatography, the residue was eluted with dichloromethane–
methanol (4:1) to give 9 (200 mg, 86.6%): m.p. 162–164 C; Rf = 0.26 in dichloro-
methane–methanol (4:1); IR (KBr) max/cm–1: 3422vsb, 1786vs, 1671–1594vsb, 1523s,
1414s, 1388m, 1336vs, 1253w, 1215w, 1132s, 1059w, 1014mb, 952w, 896m, 847vw,
763m, 732m, 697vw, 644m, 598m; 1H NMR (DMSO-d6) /ppm: 1.12 and 1.14 (6H, 2s,
CHMe2), 1.40 and 1.48 (6H, 2s, CMe2), 2.66 (3H, s, Me), 3.17 (1H, d, J = 4.7 Hz,
C1’H), 3.33–3.51 (1H, m, CHMe2), 4.15 (1H, d, J = 5.1 Hz, NH-S), 4.98 (1H, d, J = 5.4
Hz, C2H), 5.88 (1H, dd, J = 5.4 and 9.3 Hz, C3H), 6.94 (1H, d, J = 4.8 Hz, OH),
7.42–7.58 (4H, m, C6H4), 8.72 (1H, d, J = 9.3 Hz, CONH); 13C NMR (DMSO) /ppm:
12.5, 19.1, 22.5, 23.6, 24.5, 45.8, 57.7, 63.0, 71.1, 72.8, 98.7, 113.1, 127.5, 127.8,




Oxirane 5 (200 mg, 0.32 mmol) was dissolved in dichloromethane (6 mL). Hydro-
gen chloride (gaseous) was introduced into the reaction solution at room tempera-
ture to saturation. The resulting mixture was stirred at room temperature for 3
hours and evaporated under reduced pressure. The residue, after being worked up
with dichloromethane (2  10mL), yielded 10 as a yellowish foam (200 mg), which
was not purified: Rf = 0.38 in dichloromethane–ethylacetate (15:1); IR (CH2Cl2) max/cm–1:
3400s, 1765vs, 1730s, 1675vs, 1605s, 1515s, 1505s, 1455–1410s,b, 1390–1370s,b,
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1260s, 1220s, 1160s, 1060w, 1000m, 900m, 735s, 700m; 1H NMR (CDCl3) /ppm: 1.17
(6H, 2d, J = 6.4 Hz, CHMe2), 1.33 and 1.42 (6H, 2s, CMe2), 2.79 (3H, s, Me) 3.55–
3.62 (1H, m, CHMe2), 4.32 (1H, s, OH), 4.56 (1H, d, J = 6.9 Hz, S-NH), 5.08 (1H, d, J
= 5.4 Hz, C2H), 5.15 and 5.26 (2H, 2d, J = 12 Hz, CH2) 5.86 (1H, dd, J = 5.4 and 10.2




The solution of oxirane 7 (30 mg, 0.06 mmol) in dichloromethane (4 mL) was
cooled at 0 C and hydrogen chloride (gaseous) was introduced to saturation. The re-
action mixture was stirred at 0 C for 30 min. and evaporated in vacuo. The residue
was worked up with dichloromethane two times (4 mL) to yield 11 as a yellowish
foam (30 mg), which was not purified: Rf = 0.62 in dichloromethane–ethylacetate
(4:1); IR (CH2Cl2) max/cm–1: 3386mb, 1758vs, 1670s, 1608m, 1523m, 1452m, 1375m,
1340w, 1261m, 1222m, 1174m, 1132w, 1058w, 1034w, 732w, 698m; 1H NMR (CDCl3)
/ppm: 1.33 and 1.45 (6H, 2s, CMe2), 2.05 (3H, s, OCOCH3), 2.73 (3H, s, Me) 4.87
(1H, d, J = 7.7 Hz, C3H), 5.20–5.29 (3H, m, CH2 and OH), 5.71 (1H, d, J = 7.7 Hz,
CONH), 6.08 (1H, s, C2H), 7.28–7.53 (9H, m, C6H4 and C6H5).
(2S,3R)-2-Acetyloxy-3-3’-(o-chlorophenyl)-5’-methylisoxazol-4’-ylcarbonyl-
amino-4-oxoazetidine (12)
Oxirane 7 (100 mg, 0.17 mmol) was dissolved in toluene (5 mL) and p-toluene-
sulfonic acid (10 mg) was added. The reaction solution was stirred at room tempera-
ture for 1.5 hour, then extracted with a saturated aqueous solution of sodium hydro-
gen carbonate. The layers were separated; the organic layer was dried (Na2SO4) and
filtered. Evaporation of the organic layer under reduced pressure gave a white foa-
my solid, which, after purification by silica gel column chromatography, was eluted
with dichloromethane–ethylacetate (4:1) to give azetidinone 12 as a white foam: m.p.
174–175 C (30 mg; 49.7%); Rf = 0.16 in dichloromethane–ethylacetate (4:1); IR
(KBr) max/cm–1: 3347m, 3269m, 1789vs, 1750vs, 1670vs, 1608m, 1528mb, 1370m,
1234vs, 1154w, 1038s, 773vw; 1H NMR (CDCl3) /ppm : 2.11 (3H, s, OCOCH3), 2.76
(3H, s, Me), 4.57 (1H, d, J = 6.9 Hz, C3H), 5.76 (2H, s, C2H and NH), 6.69 (1H, s,
CONH), 7.45–7.59 (4H, m, C6H4).
X-ray Analysis of 5
Crystal data and details of data collection and structure determination are listed
in Table I.
Supplementary Materials. – Crystallographic data on the structure have been de-
posited at the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge
CB2 1EZ, UK (fax: +44 1223 336033; e-mail: deposit@ccdc.cam.ac.uk) and can be ob-
tained on request, free of charge, by quoting the publication citation and the depo-
siton number CCDC 165712.
Acknowledgment. – The authors are grateful to Mrs. \ur|ica Lugari} for techni-
cal assistance.
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TABLE I












Crystal size /mm 0.21  0.36  0.21
 (Mo-K) / cm–1 2.5
Diffractometer Enraf-Nonius CAD4
Radiation /Å l(Mo-K) = 0.71073
graphite monochromator
Temperature /K 295
min, max /° for cell det. 4.56, 15.95
No. of reflections used for cell det. 23
min, max /° 2.50, 33.07
(/2scan) /°  = 0.64 + 0.71 tan 
h, k, l limits 0, 15; –22, 0; –30, 0
Independent reflections observed
with I > 4	(I) 1227
No. of parameters 364
Refinement on: F2 a
R, wR 0.058, 0.166 b
Goodness of fit, S 0.883




min) / e Å–3 0.38, –0.31
Data collection and cell refinement CAD-4 EXPRESS7
Data reduction HELENA8
Program used to solve structure SHELX 869
Program used to refine structure SHELXL 9310
a Refinement on F2 where P = (Fo2 + 2Fc2) / 3.
b
R(F) = 0.058 for I > 4	(I); wR(F2) = 0.166 for all data.
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Sinteza, obja{njenje strukture i reaktivnost novih azetidinon-oksirana
Mirjana Tomi}, Mi}e Kova~evi}, Snje`ana Antoli} i Biserka Koji}-Prodi}
Oksidacijom 2,3-cis-2-sulfonamid-N-butenoat-azetidininona 3 i 2,3-trans-2-ace-
toksi-N-butenoat-azetidinona 6 dobiveni su azetidinon-oksirani 5 i 7. Molekularna
struktura i apsolutna konfiguracija spoja 5 utvr|ena je röntgenskom strukturnom
analizom. Cijepanje benzilne esterske skupine reakcijom s alumunijevim trikloridom
u anisolu kao i hidrogenolizom uz paladij na ugljenu nije dalo o~ekivane rezultate.
Umjesto toga prona|ene su nove metode za uklanjanje supstituenata s azetidinon-
skog du{ika kod spojeva 5 i 7. U reakciji azetidinon-oksirana 5 s aluminijevim triklo-
ridom u anisolu dobiven je spoj 8. Hidrogenacijom azetidinon-oksirana 5 nastaje na-
trijeva sol ß-hidroksi kiseline 9 koja u kiselom mediju daje azetidinon 8. U reakciji
sa klorovodi~nom kiselinom spojevi 5 i 7 daju azetidinon-halohidrine 10 i 11, i to
otvaranjem oksiranskog prstena. Novi azetidinonski derivati (monobaktami) nisu
pokazali znatniju antibakterijsku aktivnost niti sinergisti~ku aktivnost s amoksici-
linom.
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